Atherosclerosis
Volume 205, Issue 2 , Pages 603-607 , August 2009

Small dense LDL-cholesterol determined by a simple precipitation assay for screening familial combined hyperlipidemia

  • Tsutomu Hirano

      Affiliations

    • Department of Diabetes, Metabolism, and Endocrinology, Showa University, School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 3 37848947; fax: +81 3 37848948.
    • ,
  • Kyoko Nohtomi

      Affiliations

    • Department of Diabetes, Metabolism, and Endocrinology, Showa University, School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan
    • ,
  • Yoshikatsu Sato

      Affiliations

    • Research and Development Department, Denka Seiken Co., Ltd., Tokyo, Japan
    • ,
  • Kunio Kamata

      Affiliations

    • Research and Development Department, Denka Seiken Co., Ltd., Tokyo, Japan
    • ,
  • Yasuki Ito

      Affiliations

    • Research and Development Department, Denka Seiken Co., Ltd., Tokyo, Japan

Received 24 October 2008 ,Revised 7 January 2009 ,Accepted 9 January 2009.

References 

  1. Goldstein JL, Schrott HG, Hazzard WR, et al. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973;52:1544–1568
  2. Voors-Pette C, de Bruin TW. Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity. Atherosclerosis. 2001;157:481–489
  3. Sniderman AD, Castro Cabezas M, Ribalta J, et al. A proposal to redefine familial combined hyperlipidaemia—third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European Society for Clinical Investigation. Eur J Clin Invest. 2002;32:71–73
  4. Veerkamp MJ, de Graaf J, Bredie SJ, et al. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study. Arterioscler Thromb Vasc Biol. 2002;22:274–282
  5. Saito Y. The Japan Atherosclerosis Society Guidelines for Diagnosis and Treatment of Atherosclerotic Cardiovascular Disease 2002 (Editorial). J Atheroscler Thromb. 2004;11:101–103
  6. Teramoto T, Sasaki J, Ueshima H, et al. Primary hyperlipidemia. J Atheroscler Thromb. 2008;15:49–51
  7. Hirano T, Ito Y, Yoshino G. Measurement of small dense low-density lipoprotein particles. J Atheroscler Thromb. 2005;12:67–72
  8. Hirano T, Ito Y, Saegusa H, et al. A novel and simple method for quantification of small, dense LDL. J Lipid Res. 2003;44:2193–2201
  9. Hirano T, Ito Y, Koba S, et al. Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler Thromb Vasc Biol. 2004;24:558–563
  10. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 1986;128:417–433
  11. Austin MA, King MC, Vranizan KM. Atherogenic lipoprotein phenotype A proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495–506
  12. Veerkamp MJ, de Graaf J, Hendriks JC, et al. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study. Circulation. 2004;109:2980–2985
  13. Pajukanta P, Porkka KV. Genetics of familial combined hyperlipidemia. Curr Atheroscler Rep. 1999;1:79–86
  14. Maruyama T, Yamashita S, MatsuzawaY , et al. Research Committee on Primary Hyperlipidemia of the Ministry of Health and Welfare of Japan Mutations in Japanese subjects with primary hyperlipidemia—results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996. J Atheroscler Thromb. 2004;11:131–145
  15. Venkatesan S, Cullen P, Pacy P, et al. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb. 1993;13:1110–1118
  16. Aguilar-Salinas CA, Hugh P, Barrett R. A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism kinetics of apolipoprotein B during placebo and pravastatin therapy. Arterioscler Thromb Vasc Biol. 1997;17:72–82
  17. Georgieva AM, van Greevenbroek MM, Krauss RM, et al. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype. Arterioscler Thromb Vasc Biol. 2004;24:744–749
  18. Kwiterovich PO, White S, Forte T, et al. Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia. Arteriosclerosis. 1987;7:211–225
  19. Sniderman A, Shapiro S, Marpole D, et al. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci USA. 1980;77:604–608
  20. Ogita K, Ai M, Tanaka A, et al. Circadian rhythm of serum concentration of small dense low-density lipoprotein cholesterol. Clin Chim Acta. 2007;376:96–100
  21. Ogita K, Ai M, Tanaka A, et al. Serum concentration of small dense low-density lipoprotein-cholesterol during oral glucose tolerance test and oral fat tolerance test. Clin Chim Acta. 2008;387:36–41
  22. de Graaf J, Veerkamp MJ, Stalenhoef AF. Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids. J R Soc Med. 2002;12(Suppl.):46–53
  23. Brouwers MC, Cantor RM, Kono N. Heritability and genetic loci of fatty liver in familial combined hyperlipidemia. J Lipid Res. 2006;47:2799–2807
  24. Sniderman A, Bailey SD, Engert JC. Familial combined hyperlipidaemia: how can genetic disorders be common, complex and comprehensible?. Clin Sci. 2007;113:365–367
  25. Koba S, Hirano T, Ito Y, et al. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases. Atherosclerosis. 2006;189:206–214

PII: S0021-9150(09)00052-5

doi: 10.1016/j.atherosclerosis.2009.01.009

Atherosclerosis
Volume 205, Issue 2 , Pages 603-607 , August 2009

Article Tools

* Image Usage & Resolution